- Home
- AVNW vs RNAC Comparison
AVNW vs RNAC Comparison
Compare AVNW & RNAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVNW
- RNAC
- Stock Information
- Founded
- AVNW 2006
- RNAC 2007
- Country
- AVNW United States
- RNAC United States
- Employees
- AVNW N/A
- RNAC N/A
- Industry
- AVNW Radio And Television Broadcasting And Communications Equipment
- RNAC Biotechnology: Pharmaceutical Preparations
- Sector
- AVNW Technology
- RNAC Health Care
- Exchange
- AVNW Nasdaq
- RNAC Nasdaq
- Market Cap
- AVNW 274.4M
- RNAC 276.3M
- IPO Year
- AVNW 2007
- RNAC 2016
- Fundamental
- Price
- AVNW $22.35
- RNAC $10.64
- Analyst Decision
- AVNW Strong Buy
- RNAC Strong Buy
- Analyst Count
- AVNW 5
- RNAC 4
- Target Price
- AVNW $37.60
- RNAC $40.00
- AVG Volume (30 Days)
- AVNW 104.5K
- RNAC 48.0K
- Earning Date
- AVNW 11-04-2025
- RNAC 11-06-2025
- Dividend Yield
- AVNW N/A
- RNAC N/A
- EPS Growth
- AVNW N/A
- RNAC N/A
- EPS
- AVNW N/A
- RNAC N/A
- Revenue
- AVNW $435,926,000.00
- RNAC $1,026,000.00
- Revenue This Year
- AVNW $8.50
- RNAC N/A
- Revenue Next Year
- AVNW $5.18
- RNAC N/A
- P/E Ratio
- AVNW N/A
- RNAC N/A
- Revenue Growth
- AVNW 14.58
- RNAC N/A
- 52 Week Low
- AVNW $12.96
- RNAC $8.46
- 52 Week High
- AVNW $26.87
- RNAC $26.50
- Technical
- Relative Strength Index (RSI)
- AVNW 49.22
- RNAC 45.82
- Support Level
- AVNW $21.60
- RNAC $9.85
- Resistance Level
- AVNW $24.50
- RNAC $10.48
- Average True Range (ATR)
- AVNW 0.90
- RNAC 0.53
- MACD
- AVNW 0.02
- RNAC -0.04
- Stochastic Oscillator
- AVNW 38.57
- RNAC 44.76
About AVNW Aviat Networks Inc.
Aviat Networks Inc is a networking solutions provider. It designs, manufactures and sells wireless networking products, solutions, and services to mobile and fixed operators, private network operators, government agencies, transportation and utility companies, public safety agencies, and broadcast network operators around the world. The company's product categories include point-to-point microwave and millimeter wave radios that are licensed (subject to local frequency regulatory requirements), lightly licensed and license-exempt (operating in license-exempt frequencies), and element and network management software.
About RNAC Cartesian Therapeutics Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The company leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function.